HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NAD: Ingredient Studies Do Not Support Collagen Filler Supplement Claims

This article was originally published in The Rose Sheet

Executive Summary

Two months after referring advertising for New Nordic USA's Hair Volume supplement to the Federal Trade Commission, the National Advertising Division zeroes in on claims for the firm's Skin Care Collagen Filler supplement. According to NAD, the advertiser should discontinue anti-wrinkle and collagen-building claims for the product in the absence of reliable evidence derived from well-controlled human clinical testing.

You may also be interested in...

NAD Tugs On FTC's Sleeve Again About New Nordic Supplement Claims

New Nordic says it is in the process of reformulating its Skin Care Collagen Filler dietary supplement and updating advertising claims to more closely reflect its testing, but that doesn't excuse the firm from complying with previous NAD recommendations, the watchdog group says. NAD is referring New Nordic claims to the Federal Trade Commission for the second time in six months.

FTC Updates Endorsement Guide Resource: 'What People Are Asking'

Agency's updated FAQ web page tackles questions stakeholders have been asking in recent years about its Endorsement Guide, including the appropriate way to provide disclosures on social-media platforms and the responsibilities of companies using large networks of bloggers and other influencers to promote products.

Unfairly Hit By Influencer Assassins? Now Could Be Your Chance To Engage The FTC

Brands unfairly attacked by powerful influencers could raise the subject with the US Federal Trade Commission, which is asking for comments on its “Endorsement Guides."  




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts